Once-A-Day Treatment for Asthma

References: 1. Bleecker ER et al. J Allergy Clin Immunol Pract. 2014;2(5):553-61. 2. Breo Ellipta Data Sheet, GSK New Zealand available at www.medsafe.govt.nz. Accessed May 2022. 3. Breo Ellipta Consumer Medical Information, GSK New Zealand, available at www.medsafe.govt.nz. Accessed May 2022 4. PHARMAC Pharmaceutical Schedule May 2022, available at https://schedule.pharmac.govt.nz/ScheduleOnline.php?osq=Breo+Ellipta Accessed May 2022. 5. Beasley R, et al. The New Zealand Medical Journal; 2020; 133; 1-35

Breo Ellipta (fluticasone furoate/vilanterol trifenatate inhaler 100/25mcg per inhalation) is a Prescription Medicine. Breo Ellipta is used for the regular treatment of asthma (12 years of age and older) and for adults with Chronic Obstructive Pulmonary Disease (COPD). Breo Ellipta 100/25mcg is a fully funded medicine; Breo Ellipta 200/25mcg is a private purchase medicine (dose indicated in asthma only). Use strictly as directed. Breo Ellipta is not for relief of acute symptoms; a separate reliever inhaler may be required. Always carry your reliever inhaler. Do not discontinue Breo Ellipta abruptly. This medicine has risks and benefits.  Tell your doctor: If you are taking any other medicines or herbal remedies, you have liver disease, heart problems, high blood pressure, pulmonary tuberculosis (TB), infection of the lungs (pneumonia) or weak bones (oesteoporosis). Side Effects: Headache, common cold, oral thrush, infection of the nose sinuses or throat, flu (influenza), pain and irritation at the back of the mouth and throat, inflammation of the sinuses, pneumonia (in patients with COPD) and weakening of the bones, leading to fractures. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information see Breo Ellipta Consumer Medicine Information at www.medsafe.govt.nz. Normal doctor’s charges apply. Ask your doctor if Breo Ellipta is right for you.

Ventolin (salbutamol) is available as an alcohol-free and CFC-free inhaler, 100mcg per actuation. Ventolin is a partially funded Prescription Medicine.  You will need to pay a part charge for this medicine, which may vary across pharmacies.  Ventolin is a short-acting bronchodilator used for the relief of acute asthma symptoms. Use strictly as directed.  Do not use Ventolin if you are sensitive to any of the ingredients in the preparation.  This medicine has risks and benefits. Tell your doctor: If you feel that the medicine has become less effective or you are using more than usual, have hyperthyroidism, high blood pressure, cardiovascular disease, diabetes, or if you are taking any other medicine or herbal remedy. Side Effects: Headache, nausea, shaky or tense feeling, fast or irregular heartbeat, ‘warm’ feeling (caused by blood vessels expanding under the skin), mouth or throat irritation, shortness of breath or wheezing. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information see Ventolin Consumer Medicine Information at www.medsafe.govt.nz. Normal doctor’s charges apply. Ask your doctor if Ventolin is right for you.

Trademarks are owned by or licensed to the GSK group of companies. ©2022 GSK group companies or its licensor. Breo Ellipta was developed in collaboration with Innoviva Inc. Marketed by GlaxoSmithKline NZ Limited, Auckland. Adverse events involving GlaxoSmithKline products should be reported to GSK Medical Information on 0800 808 500. Date of Approval 05 2023. Date of Expiry 05 2025. TAPS NP1808-PM-NZ-FFV-ADVR-200001